Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effects of CBD and THC in Chronic Pain
NCT04226690Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol and dronabinol in chronic pain (3 arms), sponsored by Yale University. Primary endpoint: Pain Ratings at Day 7. Started Nov 2022; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04226690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04226690.